Is atrial fibrillation a risk factor for contrast-induced nephropathy in patients with ST-elevation myocardial infarction?

Creative Commons License

Balli M., Tasolar H., Cetin M., Hatem E., ÇAĞLIYAN Ç. E. , Seker T., et al.

JOURNAL OF CARDIOLOGY, cilt.67, ss.327-330, 2016 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 67
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1016/j.jjcc.2015.09.018
  • Dergi Adı: JOURNAL OF CARDIOLOGY
  • Sayfa Sayısı: ss.327-330

Özet

Background: Contrast-induced nephropathy (CIN) is an iatrogenic problem in patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI). Atrial fibrillation (AF) may also contribute to impaired kidney function. Several factors may contribute to the development of CIN. In patients with STEMI, concomitant AF is associated with higher in-hospital/follow-up mortality and morbidity. Therefore, we aimed to investigate the relationship between AF and CIN developments.